Ito Saki, Oh Jae K, Michelena Hector I, Egbe Alexander C, Connolly Heidi M, Pellikka Patricia A, Nkomo Vuyisile T, Lewis Bradley R, Miranda William R
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
JACC Cardiovasc Imaging. 2025 Feb;18(2):166-176. doi: 10.1016/j.jcmg.2024.07.025. Epub 2024 Sep 18.
Clinical features and outcomes in severe aortic stenosis (AS) have been described according to the hemodynamic phenotypes.
The aim of this study was to investigate the clinical features and prognosis of patients with high-gradient (HG) AS with aortic valve area (AVA) >1.0 cm.
A total of 3,209 patients were identified according to AVA (cm), peak velocity (m/s), systolic mean pressure gradient (MG) (mm Hg): HG-AVA >1 = >1.0, ≥4, and ≥40, HG-AVA ≤1 = ≤1.0, ≥4, and ≥40; LG-AVA ≤1 (low-gradient) = ≤1.0, <4, and <40; moderate AS = 1.0 <AVA ≤1.5, 3 ≤ peak velocity <4, and 20 ≤ MG <40.
HG-AVA >1 accounted for 230 individuals (7.2%). Compared with others, patients with HG-AVA >1 were younger (70.2 ± 12.0 years), more frequently male (85.7%), had fewer comorbidities, larger body surface area and stroke volume (115 ± 19.3 mL), and had higher prevalence of bicuspid valve (39.6%). After a follow-up of 944 days (Q1-Q3: 27-2,212 days), 1,523 deaths occurred. Compared with the HG-AVA >1 group, all-cause mortality was higher in HG-AVA ≤1 (HR: 1.4; 95% CI: 1.1-1.7), LG-AVA ≤1 (HR: 2.8; 95% CI: 2.2-3.6), and moderate AS (HR: 1.4; 95% CI: 1.1-1.7). These differences were no longer significant after adjustment for age, comorbidities, bicuspid valve, and cardiac function. In the HG-AVA >1 group, patients with aortic valve replacement had better survival outcomes than those without aortic valve replacement (P < 0.001) after balancing the 2 groups.
The underlying relative high-flow status is responsible for HG in patients with HG-AVA >1. This profile has better prognosis than others, being related to underlying younger age and better general and cardiac conditions, but aortic valve replacement may still benefit these patients.
严重主动脉瓣狭窄(AS)的临床特征和预后已根据血流动力学表型进行了描述。
本研究旨在调查主动脉瓣面积(AVA)>1.0 cm²的高梯度(HG)AS患者的临床特征和预后。
根据AVA(cm²)、峰值速度(m/s)、收缩期平均压力阶差(MG)(mmHg)共纳入3209例患者:HG-AVA>1=AVA>1.0、峰值速度≥4且MG≥40;HG-AVA≤1=AVA≤1.0、峰值速度≥4且MG≥40;LG-AVA≤1(低梯度)=AVA≤1.0、峰值速度<4且MG<40;中度AS=1.0<AVA≤1.5、3≤峰值速度<4且20≤MG<40。
HG-AVA>1组有230例患者(7.2%)。与其他组相比,HG-AVA>1组患者更年轻(70.2±12.0岁),男性更常见(85.7%),合并症更少,体表面积和每搏输出量更大(115±19.3 mL),二叶式瓣膜患病率更高(39.6%)。随访944天(四分位间距:27-2212天)后,发生1523例死亡。与HG-AVA>1组相比,HG-AVA≤1组(HR:1.4;95%CI:1.1-1.7)、LG-AVA≤1组(HR:2.8;95%CI:2.2-3.6)和中度AS组(HR:1.4;95%CI:1.1-1.7)的全因死亡率更高。在对年龄、合并症、二叶式瓣膜和心功能进行调整后,这些差异不再显著。在HG-AVA>1组中,在两组平衡后,接受主动脉瓣置换的患者比未接受主动脉瓣置换的患者有更好的生存结局(P<0.001)。
HG-AVA>1患者中潜在的相对高流量状态是导致高梯度的原因。该表型的预后比其他表型更好,这与潜在的年轻年龄以及更好的全身和心脏状况有关,但主动脉瓣置换仍可能使这些患者受益。